Home » Headlines » Currently Reading:

Morning Headlines 3/13/14

March 12, 2014 Headlines No Comments

Late on restatement, Accretive expects stock to be delisted

Accretive Health, a healthcare focused revenue cycle management firm and debt collector, announces that it will miss its deadline to file restated financial statements and expects that the NYSE will delist it as a result.

GAO comes down on meaningful use program

A GAO report finds that the EHR Incentive Program is not helping CMS improve overall quality because there are "reliability issues" within the clinical quality measures data that is being collected. The report concludes, "Although HHS expects that the use of EHRs can help achieve improved outcomes and support other efforts that are also intended to improve care, that result is not yet assured."

EHR Incentive Program Exceeds $22.5 Billion Payout Estimate

According to the January 2014 EHR Incentive Payment report, $22.7 billion has been paid out in incentive payments to hospitals and providers thus far, passing CMS’s estimate for what the total cost would be for the program over a 10-year timeframe.

Leidos Awarded Contracts by Department of Veterans Affairs

Leidos, an SAIC spinoff made up of former MaxIT and Vitalize consulting firms, signs a $16 million deal with the VA to provide IT support for several health IT initiatives, including technical development services for the VA’s Repositories Program, an project that will consolidate administrative and clinical data from across all VA sites into a single set of databases that centralize EHR data within the VA.



HIStalk Featured Sponsors

     







Text Ads


Recent Comments

  1. You note that, "What they need is the same level of sick leave time that many other workers in the…

  2. Re: AR outsourcing at Epic - Getting billing under control after an implementation was always one of the pain points,…

  3. Wow, your Zoom/Teams/Skype skills must be better than mine! "She noted that she thinks relationships are deeper because there has…

  4. The Ars article is all opinion and fluff, yet curiously you do not indict any of the specific content of…

Tweets

Founding Sponsors


 

Platinum Sponsors


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gold Sponsors


 

 

 

 

 

 

 

 

 

Sponsor Quick Links